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ABSTRACT The survival of any microbe relies on its ability to respond to environ-
mental change. Use of extracytoplasmic function (ECF) RNA polymerase sigma ()
factors is a major strategy enabling dynamic responses to extracellular signals. Strep-
tomyces species harbor a large number of ECF  factors, nearly all of which are un-
characterized, but those that have been characterized generally regulate genes re-
quired for morphological differentiation and/or response to environmental stress,
except for AntA, which regulates starter-unit biosynthesis in the production of anti-
mycin, an anticancer compound. Unlike a canonical ECF  factor, whose activity is
regulated by a cognate anti- factor, AntA is an orphan, raising intriguing questions
about how its activity may be controlled. Here, we reconstituted in vitro ClpXP pro-
teolysis of AntA but not of a variant lacking a C-terminal di-alanine motif. Further-
more, we show that the abundance of AntA in vivo was enhanced by removal of
the ClpXP recognition sequence and that levels of the protein rose when cellular
ClpXP protease activity was abolished. These data establish direct proteolysis as an
alternative and, thus far, unique control strategy for an ECF RNA polymerase  factor
and expands the paradigmatic understanding of microbial signal transduction regu-
lation.
IMPORTANCE Natural products produced by Streptomyces species underpin many
industrially and medically important compounds. However, the majority of the 30
biosynthetic pathways harbored by an average species are not expressed in the lab-
oratory. This unrevealed biochemical diversity is believed to comprise an untapped
resource for natural product drug discovery. Major roadblocks preventing the exploita-
tion of unexpressed biosynthetic pathways are a lack of insight into their regulation and
limited technology for activating their expression. Our findings reveal that the abun-
dance of AntA, which is the cluster-situated regulator of antimycin biosynthesis, is con-
trolled by the ClpXP protease. These data link proteolysis to the regulation of natural
product biosynthesis for the first time to our knowledge, and we anticipate that this will
emerge as a major strategy by which actinobacteria regulate production of their natural
products. Further study of this process will advance understanding of how expression of
secondary metabolism is controlled and will aid pursuit of activating unexpressed bio-
synthetic pathways.
KEYWORDS ClpXP, ECF sigma factors, Streptomyces, antimycin, proteolysis,
regulation of secondary metabolism
The survival of any organism relies on its ability to respond to environmental change.This feature is especially true of bacteria, which often live in hostile and fluctuating
environments. Streptomyces bacteria thrive in soils. The success of this genus of
filamentous, sporulating bacteria is linked to their complex life cycle and keen ability to
sense and respond to the surroundings. Notably, a multitude of bioactive secondary or
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specialized metabolites are produced in response to environmental cues (1). More than
half of all small-molecule therapeutics critical for human health and well-being are
derived from or inspired by Streptomyces natural products (2).
Streptomyces species typically harbor a large number of biosynthetic pathways, but
only a few of them are expressed under common laboratory conditions. The biochem-
ical diversity encoded by these silent pathways is a tremendous untapped resource for
discovery of new antibacterial agents and other therapeutics. All available data indicate
that the production of natural products is controlled predominantly at the level of
transcription. Although there are complex regulatory cascades that tightly control
expression of biosynthetic genes, they are ultimately activated, repressed, or dere-
pressed by so-called cluster-situated regulators—regulatory proteins encoded within
the biosynthetic gene cluster (BGC) (3, 4). Major roadblocks preventing the exploitation
of silent biosynthetic pathways are a lack of insight into their regulation and limited
technology for activating their expression.
Antimycins have been known for 70 years and are the founding members of a large
class of natural products widely produced by Streptomyces species (5, 6). Recently,
antimycins were shown to be potent and selective inhibitors of the mitochondrial
Bcl-2/Bcl-XL-related antiapoptotic proteins that are overproduced by cancer cells and
confer resistance to chemotherapeutic agents whose mode of action is activation of
apoptosis (7). The 25-kb antimycin (ant) BGC harbored by Streptomyces albus is
composed of 15 genes organized into four polycistronic operons: antBA, antCDE, antGF,
and antHIJKLMNO (Fig. 1) (8, 9). The regulation of the ant BGC is unusual compared to
other secondary metabolites. Its expression is regulated by FscRI, a cluster-situated
LuxR-family regulator of candicidin biosynthesis; FscRI activates expression of antBA
and antCDE (10). Importantly, antA is a cluster-situated regulator that encodes an
extracytoplasmic function (ECF) RNA polymerase  factor (AntA) that activates expres-
sion of the remaining operons: antGF and antHIJKLMNO (Fig. 1) (9).
AntA, like all ECF  factors, is similar to members of the housekeeping 70 family but
possesses only two of the four highly characteristic sigma domains: domains 2 and 4.
The 2 and 4 regions of sigma factors bind the 10 and 35 promoter elements,
respectively, and are sufficient for recruitment of RNA polymerase (11). Genes encoding
ECF  factors are almost always cotranscribed with their cognate anti- factor (12).
Anti- factors are generally transmembrane proteins, but well-characterized examples
of cytoplasmic anti- factors are known (13–15). Anti- factors selectively bind to and
sequester a partner  factor until its release is stimulated, usually by an exogenous
signal (12, 16). After the  factor is released, it recruits RNA polymerase to express a
defined regulon that usually includes the  factor–anti- factor operon itself, which
thus establishes a positive auto-feedback loop in the presence of the inducing stimulus.
Even when an ECF  factor does have a cognate anti- factor, an additional mechanism
of control can also exist, for instance, R= in S. coelicolor is processed by the Clp-protease
system (17). Streptomyces species encode a large number of ECF  factors (30 per
strain), and the small number of these that have been characterized regulate genes
required for morphological differentiation and/or responses to environmental stress
FIG 1 Schematic representation of the antimycin (ant) biosynthetic gene cluster. AT, acyltransferase;
NRPS, nonribosomal peptide synthetase; PKS, polyketide synthase; CCR, crotonyl coenzyme A
(crotonyl-CoA) carboxylase/reductase; 3-FSA, 3-formamidosalicylate. Antimycins: antimycin A1, R
1
COCH(CH3)CH2CH3, R
2 (CH2)4CH3; antimycin A2, R
1COCH(CH3)2, R
2 (CH2)4CH3; antimycin A3, R
1
COCH2CH(CH3)2, R
2 (CH2)2CH3; antimycin A4, R
1 COCH(CH3)2, R
2 (CH2)2CH3.
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and are not dedicated regulators of one biosynthetic pathway. Indeed, cluster-situated
ECF  factors have been observed previously only in the biosynthesis of lantibiotics
produced by so-called rare actinomycetes. In Microbispora corallina, MibR and MibX
regulate microbisporicin biosynthesis and MibX is controlled by the anti- factor MibW
(18); in Planomonospora alba, PspR and PspX regulate planosporicin production and
PspX is controlled by the anti- factor PspW (19). Interestingly, unlike the canonical ECF
 factors MibX and PspX, whose activities are controlled by cognate anti- factors,
AntA lacks an identifiable anti- factor partner and as a consequence has created
curiosity about how its activity is controlled.
The Clp-protease system is essential for normal bacterial proteostasis and is best
characterized in Escherichia coli (20, 21). The Clp protease is a multienzyme complex
composed of a barrel-shaped peptidase, ClpP, and a regulatory enzyme, either ClpA or
ClpX (or ClpC in some organisms). ClpA and ClpX (and ClpC) are AAA-family protein
unfoldases that recognize an N-terminal and/or C-terminal recognition signal (degron)
and utilize ATP to unfold and translocate proteins to the peptidase chamber, where
they are degraded into short peptides (22). In Streptomyces species, the peptidase is
specified by two genes instead of one and is redundantly encoded (23). The primary
peptidase is encoded by clpP1P2, whose corresponding proteins form a complex with
ClpX or ClpA to facilitate normal proteostasis; the second peptidase is encoded by
clpP3P4, but its expression occurs only when the primary system is compromised (24,
25). The best-understood degron is the SsrA tag from E. coli (AANDENYALAA), which is
added cotranslationally to polypeptides stalled on ribosomes (26, 27). The E. coli SsrA
tag has been comprehensively studied, and Ala-Ala-COO-, at the C-terminal region of
this motif, is essential for proteolysis by ClpXP (28). Intriguingly, the C terminus of AntA
harbors the sequence Ala-Ala-COO-, which previously led us to speculate that ClpXP
may modulate its level/activity (9).
Here, we reconstituted ClpXP proteolysis of AntA in vitro and showed that it is
dependent upon the C-terminal Ala-Ala. We also found that the abundance of AntA in
vivo was higher when Ala-Ala was changed to Asp-Asp and that the abundance of AntA
was elevated in the absence of genes encoding the primary peptidase, ClpP, and its
unfoldase, ClpX. These data establish direct proteolysis as an alternative, and thus far
unique, control strategy of ECF RNA polymerase  factors, expanding the paradigmatic
understanding of microbial signal transduction regulation.
RESULTS AND DISCUSSION
AntA orthologues are a new subfamily of ECF  factors that regulate produc-
tion of the antimycin biosynthetic starter unit. Since its initial discovery 6 years ago,
more than 70 ant BGCs have been identified within the members of Actinobacteria,
including Actinospica, Saccharopolyspora, Streptacidiphilus, and Streptomyces (5). Each of
these BGCs harbors a single regulator, AntA (53% to 100% shared amino acid identity
across all orthologues), which lacks a cognate anti- factor partner (5, 9). Our previous
work with S. albus S4 established that AntA orthologues comprise a new subfamily of
ECF  factors (9, 29). We demonstrated that AntA is required for expression of antGF
and antHIJKLMNO, which encode a standalone ketoreductase (AntM) and proteins
required for the production/activation of the starter unit, 3-formamidosalicylate (3-FSA)
(Fig. 1). We also mapped the transcriptional start sites and identified conserved
promoter sequences for these operons in all ant BGCs known at the time (9). The
conservation of AntA and target promoters within ant BGCs from taxonomically diverse
species suggests that AntA-mediated regulation of these genes is direct. To verify this
hypothesis, we performed chromatin immunoprecipitation sequencing (ChIP-seq) with
a S. albus S4 ΔantA mutant complemented with a version of AntA with a 3xFLAG tag
at its N terminus, which we demonstrated restored antimycin production (see Fig. S2 in
the supplemental material). Analysis of the resulting data revealed only one ChIP-seq
peak across the whole chromosome for which the number of mapped reads was
enriched for both biological replicates of ΔantA/3xFLAG-antA compared to that of the
wild-type mock-immunoprecipitated control. This region corresponded to the inter-
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genic space (297 bp) between antG and antH, which upon inspection revealed a
prominent peak for the closely spaced and divergent AntA-target promoters antGp and
antHp and a second, albeit smaller peak corresponding to the 5= end of the antH coding
sequence (Fig. 2). Taken together, these data are consistent with the hypothesis that
AntA is a cluster-situated regulator that directly activates expression of genes for the
production of 3-FSA during antimycin biosynthesis.
AntA is degraded by the ClpXP protease in vitro. The activities of almost all
characterized ECF  factors are modulated by a cognate anti- factor, which is typically
a protein coencoded within the same operon. Intriguingly, AntA lacks an anti- factor
and is therefore an orphan, indicating that a unique mechanism is likely at work to
control AntA activity. An inspection of AntA amino acid sequences revealed a
C-terminal Ala-Ala in 67 of the 71 orthologues (Fig. S1). A C-terminal Ala-Ala is an
important component of a common class of degrons for the ClpXP protease (28). This
observation led us to hypothesize that the activity of AntA might be modulated by
proteolysis instead of by an anti- factor. To test this hypothesis, we performed in vitro
proteolysis. Previous work indicated that S. albus S4 AntA was insoluble when over-
produced by E. coli, so we pursued the overproduction and purification of the ortho-
logue from Streptomyces ambofaciens ATCC 23877, which has been experimentally
demonstrated to be a producer of antimycins (30). S. ambofaciens AntA (75% amino
acid identity with S. albus S4 AntA, including 13 of 15 amino acid residues at the C
terminus) was purified as an N-terminal (His)6-SUMO-fusion protein. The (His)6-SUMO
tag increases solubility and eases purification of putative substrates, without altering
recognition of C-terminal degrons by ClpXP. ClpX orthologues from E. coli and S.
ambofaciens possess 60% shared amino acid identity and therefore likely recognize
similar substrates for degradation. Thus, ClpXP from E. coli was purified (Fig. S2) and its
ability to degrade (His)6-SUMO-
AntA was assessed. Degradation of (His)6-SUMO-
AntA
was apparent as early as 2.5 min after addition of ATP, and all of the sample was
degraded by 15 min (Fig. 3). Substrates of ClpXP become resistant to proteolysis by
specific alterations of the C-terminal Ala-Ala (28). Therefore, to investigate degradation
specificity in the experiment described above, we constructed and tested a variant of
S. ambofaciens AntA in which the C-terminal Ala-Ala was mutated to Asp-Asp [(His)6-
SUMO-AntA-DD]. Strikingly, the Asp-Asp variant was stable against ClpXP degradation
over the lifetime of the assay (Fig. 3). Thus, the degradation of (His)6-SUMO-
AntA and
the characteristic resistance afforded by the Ala-Ala-to-Asp-Asp mutation demon-
strated that AntA is a substrate of ClpXP in vitro.
AntA is degraded by the ClpXP protease in vivo. To investigate if the in vitro
degradation of AntA demonstrated above is relevant to its regulation in vivo, we
deleted the operon consisting of the clpX, clpP1, and clpP2 genes from S. albus S4. The
resulting ΔclpXclpP1clpP2 mutant still harbored the second Clp peptidase encoded by
FIG 2 3xFLAG-AntA binds to the antGF and antHIJKLMNO promoters in vivo. Shown is a graphical
representation of normalized sequence reads mapped to the intergenic region of antG-antH (shown at
the bottom). The 1,242-bp genomic window depicts nucleotides 34,430 to 35,671 of contig
CADY01000091.1 of the S. albus S4 genome. Each double slash denotes that genome window presented
does not contain the entire antF or antH coding sequence. WT, wild type; IP, immunoprecipitation.
Bilyk et al.
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clpP3clpP4 and underwent a normal developmental cycle, albeit sporulation was less
robust, which is consistent with growth characteristics reported for mutation of equiv-
alent genes in S. coelicolor (Fig. S3) (31). Next, genes encoding the 3xFLAG-AntA or
3xFLAG-AntA-DD fusion proteins were generated and introduced into the parental
strain and the clpXclpP1clpP2 mutant so the abundance of these proteins could be
assessed over a developmental time course by Western blotting with anti-FLAG anti-
sera. This experiment was initially performed with the AntA fusions integrated on the
chromosome under the control of the native promoter. However, a reliable signal could
not be detected for 3xFLAG-AntA and only a trace amount of the Asp-Asp variant was
observed, presumably indicating that the cellular level of AntA is normally low because
the native promoter is relatively weak. The experiment was therefore repeated with
3xFLAG-AntA and 3xFLAG-AntA-DD expression driven by a stronger, constitutive pro-
moter, ermE* (32). Analysis of the resulting immunoblot revealed that 3xFLAG-AntA-DD
was more abundant than 3xFLAG-AntA in vegetative mycelium of the parent and
ΔclpXclpP1clpP2 strains (Fig. 4; see also Fig. S5). Strikingly, in the later stages of
development after aerial mycelium had formed (24 h and 30 h), 3xFLAG-AntA and
3xFLAG-AntA-DD were detected only in the ΔclpXclpP1clpP2 strain and not the parent;
the Asp-Asp variant was also present in greater relative abundance (Fig. 4), which was
consistent with our previous experiments that showed that the ant BGC is downregu-
lated at the level of transcription upon the onset of aerial growth (9). Interestingly, the
conspicuous absence of 3xFLAG-AntA and the presence of 3xFLAG-AntA-DD in protein
samples prepared from the latest time point sampled suggest the potential involve-
ment of an additional degradative factor(s). Taken together, these data support the
hypothesis that the levels of AntA, and thus its ability to activate gene expression of
antFGHIJKLMNO, are modulated by the ClpXP protease.
Antimycins are not overproduced in the absence of ClpXP. The results of the
experiments described above indicate that the cellular level of AntA was more abun-
dant in the absence of the ClpXP protease. In order to determine if an increased level
of this transcription factor ultimately influenced the final production titer of antimycins,
we used liquid chromatography–high-resolution mass spectrometry (LC-HRMS) to
assess the abundance of antimycins in chemical extracts generated from the
FIG 3 Proteolysis of S. ambofaciens AntA by ClpXP in vitro. (A) SDS-PAGE analysis of proteolysis reaction
mixtures containing 37 pmol (His)6SUMO-
AntA or (His)6SUMO-
AntA-DD. (B) Densitometry analysis SDS-
PAGE images for three independent proteolysis experiments. The mean is plotted, and error bars
illustrate the standard error of the mean (1 SEM).
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ΔclpXclpP1clpP2 and parental strains grown atop a cellophane disk on mannitol-soya
flour (MS) agar in triplicate. The extracted ion chromatograms representing antimycin
A1, A2, A3, and A4 were used to determine the peak area for each compound, which was
subsequently normalized based on the wet mycelium weight of the sample. Interest-
ingly, the results indicated that the total levels of antimycin production by the
ΔclpXclpP1clpP2 mutant (15.57 arbitrary units [AU]  2.86) and the parental strain
(16.59 AU  1.12) were not statistically significantly different (P value, 0.59) (see Ta-
ble S1 in the supplemental material). This result is consistent with a previous experi-
ment where overexpression of antA did not increase the titer of antimycins, because
that experiment showed that it resulted in overexpression of only antGF and antHI-
JKLMNO (genes encoding the production of the AntG-S-3-formamidosalicylate starter
unit) and not the remaining genes (antABCDE) in the BGC (9). This also presumably
indicates that starter unit biosynthesis is not rate limiting for antimycin production.
Model for the regulation of antimycin biosynthesis. Our model for the regulation
of antimycin biosynthesis is depicted in Fig. 5. Expression of the ant BGC is cross-
activated by FscRI, a LuxR-family regulator, from the candicidin BGC, which activates
expression of antBA and antCDE (10). This regulation in turn enables direct activation of
the 3-FSA biosynthetic operons (antGF and antHIJKLMNO) by AntA. The expression of
antBA and antCDE is downregulated following the onset of morphological differentia-
tion, presumably because the ligand sensed by the FscRI PAS domain is no longer
available (9, 10). The cellular level of AntA is antagonized by the ClpXP protease, for
which it is a direct target, and is ultimately responsible for clearing residual AntA when
FscRI is inactivated following the onset of morphological differentiation (10). While
ClpXP proteolytic control of transcription factor activity, and in particular that of ECF 
factor/anti- factors, has been shown previously (33–41), it has thus far not been
directly linked to the control of cluster-situated regulators of natural product biosyn-
thesis. This finding provides a new lens through which to examine microbial signal
transduction and the regulation of natural product biosynthesis in Streptomyces spe-
FIG 4 The abundance of AntA is enhanced in the absence of the ClpXP in vivo. Cells from the indicated
strains were cultivated over a developmental time course atop cellophane discs on agar media. Protein
was isolated from 100 mg of either vegetative mycelium (14 and 17 h) or aerial mycelium (24 and 30 h).
Thirty-microgram volumes of total protein were analyzed by Western blotting with anti-FLAG antisera.
The images shown are derived from uncropped original images shown in Fig. S4 in the supplemental
material, and the corresponding densitometry analysis is shown in Fig. S6.
Bilyk et al.
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cies. Understanding the diversity of regulatory strategies controlling the expression of
these pathways is critical for the development of new tools for exploiting the “silent
majority” of biosynthetic pathways harbored by these organisms.
MATERIALS AND METHODS
Growth media, strains, cosmids, plasmids, and other reagents. Escherichia coli strains were
propagated on Lennox agar (LA) or broth (LB) (42, 43), and Streptomyces albus S4 strains were cultivated
using LA, LB, and mannitol-soya flour (MS) agar or broth (42). Development of clp mutants was assessed
on MS and ISP2 medium (42). Culture medium was supplemented with antibiotics as required at the
following concentrations: apramycin, 50 g ml1; carbenicillin, 100 g ml1; chloramphenicol, 25 g
ml1; hygromycin, 50 g ml1; kanamycin, 50 g ml1; nalidixic acid, 25 g ml1. Streptomyces strains
were constructed by conjugal mating with E. coli ET12567 as previously described (42). Enzymes were
purchased from New England Biolabs unless otherwise stated, and oligonucleotides were purchased
from Integrated DNA Technologies, Inc. All of the strains, cosmids, and plasmids used in this study are
described in Table S2 in the supplemental material, and all of the oligonucleotides used are provided in
Table S3.
Construction of plasmids. The insertion for each plasmid generated in this study was prepared by
PCR amplification with Q5 High-Fidelity DNA polymerase and oligonucleotides containing restriction
sites. PCR-amplified insertions were restricted and cloned into the relevant plasmids cut with the same
enzymes by standard molecular biology procedures. All clones were sequenced to verify the integrity of
insertion DNA. The names of the restriction sites used for cloning are provided with the plasmid
descriptions in Table S2.
ChIP-seq and bioinformatics analyses. The antA coding sequence was amplified with RFS629 and
RFS630, which contain KpnI and EcoRI restriction sites, respectively. The restricted PCR product was
cloned into pSETNFLAG (10) digested with the same enzymes. The resulting plasmid was then restricted
with NotI and EcoRI to release ermE*p-3xFLAG-antA, which was subsequently cloned into pAU3-45 (44)
digested with the same enzymes. pAU3-45-3xFLAG-antA was mobilized to an apramycin-marked ΔantA
strain (9). Cultivations of the wild-type and ΔantA/pAUNFLAG-antA strains for ChIP-seq were performed
exactly as described previously (10). Pure DNA resulting from immunoprecipitates from two biological
FIG 5 Model for the regulation of antimycin biosynthesis. The upper panel displays the relative locations
of the antimycin and candicidin BGCs in the S. albus S4 chromosome. As shown in the lower panel, FscRI,
a LuxR-family regulator, from the candicidin BGC, activates expression of antBA and antCDE. This in turn
enables direct activation of the 3-FSA biosynthetic operons (antGF and antHIJKLMNO) by AntA. The
cellular level of AntA is antagonized by the ClpXP-protease system, for which it is a direct target and is
ultimately responsible for clearing residual AntA when FscRI is inactivated following the onset of
differentiation.
Antimycin Biosynthesis Is Controlled by ClpXP
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replicates of the wild-type and ΔantA/pAUNFLAG-antA strains and nonimmunoprecipitated chromo-
somal DNA were sequenced with a Illumina HiSeq 3000 platform with 150-nucleotide (nt) paired-end
reads by the University of Leeds Next Generation Sequencing Facility at the St. James Teaching Hospital
NHS Trust. The resulting reads were analyzed exactly as described previously (10). The graphic in Fig. 2
was generated using DeepTools computeMatrix in scale-regions mode with a bin size of 54 and
plotProfile functions (45).
Construction of the S. albus S4 clpXclpP1clpP2 mutant strain. Deletion of clpXclpP1clpP2 was
carried out using RecET recombineering in E. coli as follows. The clpXclpP1clpP2-containing cosmid,
cos117, was obtained by screening a previously constructed S. albus S4 Supercos1 cosmid library (8) by
PCR using oligonucleotides PBB001 and PBB002. Cos117 was mutagenized as required using E. coli
recombineering with strain GB05-red (46) and a deletion cassette. The deletion cassette was generated
by PCR from paac-apr-oriT (47) and consisted of the aac(3)IV apramycin resistance gene and a conjugal
origin of transfer (oriT), which was flanked by 	C31-attL and 	C31-attR sites for excision of the cassette.
The oligonucleotides used to generate deletion cassettes included 39 nt of homology upstream or
downstream of the target open reading frame(s) and are listed in Table S3. The resulting PCR product was
digested with DpnI, gel purified, and electroporated into arabinose-induced E. coli GB05-red harboring
cos117. Transformants were screened for the presence of mutagenized cosmid by PCR using oligonu-
cleotides listed in Table S3, and the integrity of the locus was verified by DNA sequencing. The
mutagenized cosmid was electroporated into E. coli ET12567/pUZ8002 and mobilized to a strain of S.
albus S4 harboring an entire antimycin BGC deletion (Δantall) (48) by conjugation as described previously
(42). Transconjugants were screened for apramycin resistance and kanamycin sensitivity. The integrity of
an apramycin-marked mutant was verified by PCR using the oligonucleotides listed in Table S3. The
apramycin deletion cassette was subsequently excised from the chromosome by conjugal introduction
of pUWLint31, which is a replicative plasmid with a temperature-sensitive origin of replication that
expresses the 	C31 integrase required for removal of the cassette (47). Transconjugants were screened
for loss of apramycin resistance, and excision of the cassette was verified by polymorphic shift PCR and
DNA sequencing of the product.
Immunoblot analysis. Spores of the parental strain and of S. albus Δantall and the ΔclpXclpP1clpP2
mutant harboring pPDA or pPDD were grown on MS agar (buffered with 50 mM TES, pH 7.2) covered
with cellophane discs. Protein was isolated from mycelium collected during growth at the following
regular intervals: 14 h, 17 h, 24 h, and 30 h for the Δantall and ΔclpXclpP1clpP2 mutants harboring
3xFLAG-AntA constructs and 17 h, 20 h, 23 h, and 30 h for the Δantall and ΔclpXclpP1clpP2 mutants
harboring the 3xFLAG-FscRI construct. Protein samples were generated as follows: 100-mg volumes of
cells were resuspended in 200 l lysis buffer (50 mM sodium phosphate buffer [pH 7.0]; 150 mM sodium
chloride; 10 mg ml1 lysozyme; cOmplete, Mini, EDTA-free protease inhibitors [Roche]; 100 mg of
0.1-mm-diameter glass beads [PowerLyzer]) and lysed by vortex mixing for 30 min at 2,000 rpm and 37°C,
with a subsequent incubation for another 30 min at 37°C. The obtained suspension was centrifuged for
20 min at 20,000 
 g at 18°C. Each clarified protein sample (30 g) was subjected to SDS-PAGE and then
transferred to a nitrocellulose membrane (pore size, 0.2 m) for Western blot analysis. The membrane
was probed with mouse monoclonal anti-FLAG M2-horseradish peroxidase (HRP) antibody (Sigma)
(1:10,000, and the signals were detected using Pierce 1-Step Ultra TMB blotting solution (Thermo
Scientific).
Protein purification and in vitro ClpXP proteolysis assays. The wild-type antA gene was PCR
amplified and cloned into the AgeI and HindIII sites of the pET23b-SUMO vector, which harbors an
N-terminal (His)6-SUMO tag (49). The plasmid for production of (His)6-SUMO-
AntA-DD was generated by
site-directed mutagenesis (Agilent QuikChange) using primers listed in Table S3. (His)6-SUMO-
AntA and
(His)6-SUMO-
AntA-DD were produced by E. coli Rosetta(DE3) (Novagen) grown in LB at 37°C until an
optical density at 600 nm (OD600) of 0.5 was reached, followed by induction with 0.4 mM IPTG
(isopropyl--D-thiogalactopyranoside) and growth at 18°C for 16 h. Cells were resuspended in 50 mM
sodium phosphate (pH 8)–1 M NaCl–20 mM imidazole–10% glycerol–1 mM dithiothreitol (DTT) and lysed
by the use of a French press at 28,000 lb/in2, followed by treatment with protease inhibitor cocktail set
III (EDTA-free) (Calbiochem), and benzonase (Millipore Sigma). (His)6-SUMO-
AntA and (His)6-SUMO-
AntA-DD proteins were purified by nickel-nitrilotriacetic acid (Ni-NTA) affinity chromatography and
Superdex-75 gel filtration and stored in 50 mM potassium phosphate (pH 6.8)–850 mM KCl–10% glyc-
erol–1 mM DTT. E. coli ClpX and ClpP proteins were purified as described previously (50, 51).
In vitro ClpXP proteolysis assays were performed at 30°C by preincubating 0.3 M ClpX6 and 0.8 M
ClpP14 with an ATP regeneration system (4 mM ATP, 50 g ml
1 creatine kinase, 5 mM creatine phos-
phate) in 25 mM HEPES-KOH (pH 7.5)–20 mM KCl–5 mM MgCl2–10% glycerol–0.032% NP-40–0.2 mM
DTT and adding substrate to initiate the reactions. Samples of each reaction mixture were taken at
specific time points, and the reactions were stopped by addition of SDS-PAGE loading dye and boiling
at 100°C before loading on Tris-Glycine-SDS gels. Bands were visualized by staining with colloidal
Coomassie G-250 and quantified by ImageQuant (GE Healthcare) after scanning by Typhoon FLA 9500
(GE Healthcare). The (His)6-SUMO-
AntA fraction remaining was calculated by dividing the (His)6-SUMO-
AntA density at a given time point by the density at time zero and normalizing by ClpX density.
Chemical analysis. S. albus S4 strains were cultivated atop a cellophane disc on MS agar at 30°C for
7 days in triplicate. At the time of harvest, the cellophane disc containing mycelium was removed and
the quantity of biomass was determined. Bacterial metabolites were extracted from both the mycelium
and the “spent” agar for 1 h using 50 ml of ethyl acetate. Thirty-milliliter volumes of ethyl acetate were
evaporated to dryness under conditions of reduced pressure, and the resulting residue was resuspended
in 100% methanol (300 l). Immediately prior to LC-HRMS analysis, methanolic extracts were centrifuged
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at 16,000 
 g in a microcentrifuge tube for 5 min to remove insoluble material. Only the supernatant
(3 l) was injected into a Bruker Maxis Impact time of flight (TOF) mass spectrometer equipped with a
Dionext Ultimate 3000 HPLC system as previously described (52). The peak area associated with the
extracted ion chromatograms for antimycin A1, A2, A3, and A4 present in agar and mycelium extracts was
determined and used to calculate the total level of antimycins produced for each replicate. These values
were subsequently used to determine the arithmetic mean for total antimycin production for each strain.
Statistical significance was assessed in Microsoft Excel by a homoscedastic Student’s t test with a
two-tailed distribution.
Data availability. The next-generation-sequencing data obtained in this study are available under
ArrayExpress accession numbers E-MTAB-7700 and E-MTAB-5122.
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